293 related articles for article (PubMed ID: 30832966)
1. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma.
Huo J; Aloia TA; Xu Y; Chung TH; Sheu T; Tina Shih YC
Value Health; 2019 Mar; 22(3):284-292. PubMed ID: 30832966
[TBL] [Abstract][Full Text] [Related]
2. Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma.
Wu CH; Liang PC; Su TH; Lin MC; Chang YH; Shih TT; Kao JH
Hepatol Int; 2021 Oct; 15(5):1247-1257. PubMed ID: 34338971
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
[TBL] [Abstract][Full Text] [Related]
4. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
[TBL] [Abstract][Full Text] [Related]
5. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?
Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X
BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation.
Liu B; Long J; Wang W; Huang G; Jiang C; Zhang X; Liu M; Liang P; Yu J; Xie X; Kuang M
Clin Radiol; 2018 Jul; 73(7):647-656. PubMed ID: 29627066
[TBL] [Abstract][Full Text] [Related]
7. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
10. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
Yuan C; Yuan Z; Cui X; Gao W; Zhao P; He N; Cui S; Wang Y; Zhang Y; Li W; Zheng J
J Cancer Res Ther; 2019; 15(4):784-792. PubMed ID: 31436232
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results.
Mu L; Sun L; Pan T; Lyu N; Li S; Li X; Wang J; Xie Q; Deng H; Zheng L; Peng J; Shen L; Fan W; Wu P; Zhao M
Int J Hyperthermia; 2018 Feb; 34(1):59-67. PubMed ID: 28540809
[TBL] [Abstract][Full Text] [Related]
14. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
Uhlig J; Sellers CM; Stein SM; Kim HS
Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs.
Cassera MA; Potter KW; Ujiki MB; Swanström LL; Hansen PD
Surg Endosc; 2011 Apr; 25(4):1088-95. PubMed ID: 20848143
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
Rhim H; Choi D; Kim YS; Lim HK; Choe BK
Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]